Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 240

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Coronary Artery Disease in End-Stage Renal Disease: No Longer a Simple Plumbing Problem

Stenvinkel, Peter, Pecoits-Filho, Roberto, Lindholm, Bengt·2003·Journal of the American Society of Nephrology

Abstract

The lifespan of patients with end-stage renal disease (ESRD) is reduced, and cardiovascular disease (CVD) accounts for a premature death in more than 50% of patients from Western Europe and North America undergoing regular dialysis (1). Actually, the risk for CVD in a 30-yr-old ESRD patient is similar to the calculated risk of a 70 to 80-yr-old subject from the nonrenal population. It is notable that the risk of cardiovascular disease seems to be substantially lower in ESRD patients of Asian origin (2). Though the prevalence of traditional Framingham risk factors is very high in ESRD, the extent and severity of cardiovascular complications is clearly disproportionate to the underlying risk factor profile (3). Therefore, much recent interest has focused on nontraditional risk factors, such as inflammation, malnutrition, and oxidative stress, all common phenomena of ESRD that may promote atherosclerosis (4,5). Although non-atherosclerotic CVD may also contribute to the high cardiovascular mortality rate in ESRD, available evidence suggests that ESRD patients are subjected to a process of accelerated atherogenesis (6). As previously discussed by London and Dru[Combining Diaeresis]eke (7), the clinical distinction between the two coexisting conditions associated with arterial disease, arteriosclerosis and atherosclerosis, may not be easy to define. Whereas arteriosclerosis is primarily a medial degenerative condition associated with aging that causes stiffening of arteries, atherosclerosis is a disease process that typically results in narrowing or occlusion of arteries (7). Although several clinical methods (such as carotid ultrasonography and coronary angiography) are available to assess the degree of arteriosclerosis and atherosclerosis in ESRD patients, it should be noted that most previous studies on the association between vascular disease and cardiovascular risk factors have used a clinical definition of CVD as a surrogate marker of vascular disease. However, there are at least two distinct but related processes in the progress of atherosclerotic coronary artery disease (CAD), (a) the slow progressive atheroma formation and (b) the instant plaque rupture with formation of an occlusive thrombus (Figure 1); therefore, a clinical definition may fail to predict the overall atherosclerotic burden. Thus the use of a clinical definition of CVD, as used in many previous studies, may be inappropriate and misleading. It should also be noted that a number of functional non-atheromatotic factors, such as abnormal vasodilation and increased extravascular resistance, might contribute to CVD in ESRD (8). Therefore, as the use of a clinical definition of CVD may not estimate the true prevalence and incidence of atherosclerosis in ESRD, it should be used with caution. The present review will focus on recent advances in the understanding and treatment of atheroma formation and plaque rupture, particularly in the context of two common features of ESRD: inflammation and oxidative stress. We will discuss new findings regarding these putative associations as documented in the recent nonrenal literature; when possible, we will also try to put these findings into the context of ESRD and its associated state of inflammation and oxidative stress. Figure 1. : (A) Biochemical, functional, and anatomic evaluation of coronary heart disease in end-stage renal disease (ESRD). (B) Schematic view of the atheroma’s development. The normal human coronary artery is composed of three layers of cells: endothelial cells resting on a basement membrane, the intimal layer (containing smooth muscle cells and extracellular matrix), and the underlying tunica media. In early atherogenesis, recruitment of inflammatory cells and the accumulation of lipids (foam cells) lead to formation of a fatty streak. If inflammatory conditions prevail and risk factors such as dyslipidemia persist, the lipid pool can grow, and proteinases secreted by the activated leukocytes can degrade the extracellular matrix and cause cell death while proinflammatory cytokines that stimulate Th1 activity can limit the synthesis of new collagen. These changes may thin the fibrous cap, making it susceptible to rupture. When rupture occurs, blood in the plaque coagulates, leading to thrombus formation and an acute coronary syndrome. Stenotic lesions may restrict flow, particularly under situations of increased cardiac demand, which leads to ischemia and symptoms such as angina pectoris. As stable stenotic plaques may be more fibrous and calcified, they are less susceptible to rupture (higher Th2 activity). (C) Therapeutic measures to be implemented according to the different evolution phases of the atherosclerotic lesion.Atherosclerosis: No Longer a Simple Plumbing Problem Not more than 10 to 15 yr ago, cholesterol deposition in atherosclerosis was considered merely a passive and degenerative process of aging. As atherosclerosis was viewed as more of a “plumbing problem,” mechanical

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.asn.0000069165.79509.42

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 240

Metadata

Authors
Stenvinkel, P., Pecoits-Filho, R., & Lindholm, B.
Venue
Journal of the American Society of Nephrology
Published
2003-07
Volume
14
Issue
7
Pages
1927-1939
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2137678094
Cited by
240
References
12
FWCI
12.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coronary Artery Disease in End-Stage Renal Disease: No Longer a Simple Plumbing Problem. https://app.cochat.ai/papers/10.1097/01.asn.0000069165.79509.42
The paper
Stenvinkel, P., Pecoits-Filho, R., & Lindholm, B. (2003). Coronary Artery Disease in End-Stage Renal Disease: No Longer a Simple Plumbing Problem. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000069165.79509.42

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.